Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV.

BMC Infectious Diseases
Esther MerliniGiulia Marchetti

Abstract

Despite the effectiveness of cART, people living with HIV still experience an increased risk of serious non-AIDS events, as compared to the HIV negative population. Whether pre-cART microbial translocation (MT) and systemic inflammation might predict morbidity/mortality during suppressive cART, independently of other known risk factors, is still unclear. Thus, we aimed to investigate the role of pre-cART inflammation and MT as predictors of clinical progression in HIV+ patients enrolled in the Icona Foundation Study Cohort. We included Icona patients with ≥2 vials of plasma stored within 6 months before cART initiation and at least one CD4 count after therapy available. Circulating biomarker: LPS, sCD14, EndoCab, hs-CRP. Kaplan-Meier curves and Cox regression models were used. We defined the endpoint of clinical progression as the occurrence of a new AIDS-defining condition, severe non-AIDS condition (SNAEs) or death whichever occurred first. Follow-up accrued from the data of starting cART and was censored at the time of last available clinical visit. Biomarkers were evaluated as both binary (above/below median) and continuous variables (logescale). We studied 486 patients with 125 clinical events: 39 (31%) AIDS, 66 (53%) SNAE...Continue Reading

References

Nov 23, 2006·Nature Medicine·Jason M BrenchleyDaniel C Douek
Oct 24, 2008·PLoS Medicine·Lewis H KullerUNKNOWN INSIGHT SMART Study Group
Apr 13, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·UNKNOWN Antiretroviral Therapy Cohort Collaboration
Jun 29, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Phyllis C TienCarl Grunfeld
Jan 22, 2011·The Journal of Infectious Diseases·Netanya G SandlerUNKNOWN INSIGHT SMART Study Group
Nov 18, 2011·AIDS·Fumiyo NakagawaAndrew N Phillips
Apr 24, 2014·The Journal of Infectious Diseases·Peter W HuntMichael M Lederman
Nov 15, 2014·Journal of the International AIDS Society·Julien SaisonGuillaume Monneret
Dec 2, 2014·Sexual Health·Clare L V WesthorpeIan Woolley
May 29, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ashwin BalagopalUNKNOWN ACTG PEARLS and NWCS 319 Study team
Jul 21, 2015·The New England Journal of Medicine·UNKNOWN INSIGHT START Study GroupJames D Neaton
Jul 21, 2015·The New England Journal of Medicine·UNKNOWN TEMPRANO ANRS 12136 Study GroupXavier Anglaret
Jan 7, 2016·Critical Reviews in Clinical Laboratory Sciences·Anne GnauckMarlena Cathorina Kruger
Mar 31, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Julia L MarcusMichael J Silverberg
Sep 15, 2016·The Journal of Infectious Diseases·Peter W HuntMark J Siedner
Jan 27, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·UNKNOWN IeDEA and COHERE Cohort Collaborations
Mar 7, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yoshikazu MutohShinichi Oka
Mar 17, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Vikram MehrajUNKNOWN Montreal Primary HIV Infection Study and Canadian HIV and Aging Cohort Study Groups
Apr 11, 2019·Frontiers in Immunology·Rayoun RamendraJean-Pierre Routy
May 14, 2020·AIDS Research and Therapy·Jing OuyangJean-Pierre Routy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.